首页> 外文期刊>Molecular Genetics and Metabolism Reports >Myopathy, lactic acidosis and sideroblastic anemia 1 (MLASA1): A 25-year follow-up
【24h】

Myopathy, lactic acidosis and sideroblastic anemia 1 (MLASA1): A 25-year follow-up

机译:肌病,乳酸性酸中毒和铁粒幼细胞性贫血1(MLASA1):25年的随访

获取原文
           

摘要

Mitochondrial myopathy, lactic acidosis and sideroblastic anemia 1 (MLASA1) is a rare disease caused by biallelic pathogenic variants in the PUS1 gene. There are eleven MLASA1 patients reported worldwide with the majority of the patients originating from the Shiraz region of Iran. The rarity of this disease poses challenges to counseling patients due to a lack of natural history data. This report reviews what is known regarding MLASA1 and describes two brothers with MLASA1 who were cared for over the course of 10?years at the University of California Los Angeles. The brothers suffered from chronic anemia, transfusion dependency and muscle wasting that lead to respiratory insufficiency and death in one of the brothers.
机译:线粒体肌病,乳酸性酸中毒和铁粒幼细胞贫血1(MLASA1)是由PUS1基因中双等位基因致病变异引起的罕见疾病。全世界报告了11例MLASA1患者,其中大多数患者来自伊朗的设拉子地区。由于缺乏自然史数据,这种疾病的罕见性给咨询患者带来了挑战。该报告回顾了有关MLASA1的已知信息,并描述了两个MLASA1兄弟,他们在加利福尼亚大学洛杉矶分校照顾了10年。兄弟俩患有慢性贫血,输血依赖和肌肉萎缩,导致其中一名兄弟呼吸衰竭和死亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号